← Back to front page
United States · Platforms & data · MarketBeat

Cellebrite DI Ltd. (NASDAQ:CLBT) Stock Has Consensus Price Target of $14.75

Published by MarketBeat · United States 24 min ago
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Is Nvidia Worth This Much Less Without Jensen Huang?

 Seeking Alpha

ArrowMark Financial declares $0.15 dividend

 Investing.com

Maharashtra Seamless Q2 FY27 slides: margins dip on inventory impact

 MarketWatch

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

 CNBC

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker

 Stocktwits

Fed Vice Chair Says AI’s Trillion-Dollar Infrastructure Push Is Adding To Inflation Pressures